Details of the Drug

General Information of Drug (ID: DMMACXS)

• Drug Name: VLA15

Indication

Disease Entry	ICD 11	Status	REF
Lyme disease	1C1G	Phase 2	[1]

• Drug Type: Vaccine
• Cross-matching ID: TTD ID: DWB8C5

References

• [1] ClinicalTrials.gov (NCT03970733) Alternative Schedule Study For VLA15, a Vaccine Candidate Against Lyme Borreliosis. U.S. National Institutes of Health.